tiprankstipranks
Trending News
More News >
Eastman Chemical (EMN)
NYSE:EMN

Eastman Chemical (EMN) AI Stock Analysis

Compare
888 Followers

Top Page

EMN

Eastman Chemical

(NYSE:EMN)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
$86.00
▲(13.95% Upside)
Action:ReiteratedDate:02/22/26
EMN scores as moderately attractive: solid but recently weaker financial performance (2025 margin/return step-down and uneven cash conversion) is partially offset by strong technical momentum and a supportive dividend yield. The earnings call points to tangible self-help and project-driven upside, but near-term macro and segment headwinds keep the overall score in the upper-middle range.
Positive Factors
Diversified specialty-materials portfolio
Eastman’s broad portfolio across advanced materials, chemical intermediates, fibers and additives exposes it to multiple end markets (automotive, packaging, construction). This diversification reduces single-market cyclicality and supports durable revenue streams as product mix shifts with demand and sustainability trends.
Material, credible cost-savings program
Management has executed meaningful, verifiable structural savings ($100m delivered; $225–250m target over two years). These recurring savings improve margin resiliency and cash flow generation even if top-line softness persists, providing a durable lever to restore profitability and fund strategic investments.
Circular/rPET ramp with large-brand contracts
The methanolysis/rPET ramp is a structural growth driver tied to secular sustainability demand and major brand contracts. Expected multi-percent revenue contribution and ~$30m incremental earnings improve structural growth mix, reduce reliance on commodity cycles, and position Eastman in higher-value circular solutions.
Negative Factors
2025 margin and profit step-down
A meaningful 2025 decline in revenue and margins signals structural pressure from weaker pricing/mix and cost headwinds. Reduced net margins and cooling returns limit internal cash generation and indicate the business remains exposed to cyclical softness until higher-margin initiatives fully scale.
Inconsistent cash conversion and working-capital swings
Although FCF is positive, weak and variable cash conversion (large swings and subpar coverage ratios) suggests working-capital or capex intensity risks. This reduces payout and investment flexibility during downturns, making the company more sensitive to earnings volatility despite nominal FCF generation.
Chemical Intermediates earnings volatility
Exposure to bulk ethylene markets creates structural earnings volatility driven by global pricing and export dynamics. Until high-return mitigants (e.g., ETP project) fully execute, CI margins remain susceptible to external commodity swings, weakening aggregate margin stability and forecasting visibility.

Eastman Chemical (EMN) vs. SPDR S&P 500 ETF (SPY)

Eastman Chemical Business Overview & Revenue Model

Company DescriptionEastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films, and aftermarket applied film products for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non- phthalate plasticizers to the industrial chemicals and processing, building and construction, health and wellness, and agrochemicals. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.
How the Company Makes MoneyEastman Chemical generates revenue primarily through the sale of its diverse portfolio of specialty chemicals and materials. The company's revenue model is based on selling products across multiple sectors, with significant contributions from advanced materials, chemical intermediates, and additives. Key revenue streams include the production of performance materials for automotive and consumer applications, as well as specialty additives used in coatings and adhesives. Eastman also engages in strategic partnerships and collaborations with various industries to innovate and expand its product offerings. Factors contributing to its earnings include a strong focus on research and development, global market reach, and adapting to evolving customer needs, particularly in sustainability and performance enhancements.

Eastman Chemical Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down revenue across different business units, highlighting which segments are driving growth and which may need strategic adjustments.
Chart InsightsEastman Chemical's revenue trends reveal resilience in Advanced Materials and Additives & Functional Products, despite anticipated volume declines. The Fibers segment faces headwinds from tariffs and weak textile demand, while Chemical Intermediates struggle with global capacity issues. The earnings call highlights a strategic focus on cost savings, innovation, and AI integration to drive future growth. Notably, the circular polyester methanolysis plant and a restructured Pepsi contract signal potential revenue boosts. However, trade challenges and a lowered Q4 outlook due to demand drops present risks to near-term performance.
Data provided by:The Fly

Eastman Chemical Earnings Call Summary

Earnings Call Date:Jan 29, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 23, 2026
Earnings Call Sentiment Positive
The call balanced clear near-term challenges (weakness in Fibers and Chemical Intermediates, tariff/destocking effects, price pressure, and a $50–$75 million variable compensation headwind) with multiple concrete mitigation and growth actions that are already yielding results: $100 million of cost savings delivered in 2025 and another $125–$150 million targeted; an ETP project that could add $50–$100 million of earnings; rPET/methanolysis ramp expected to add revenue (4%–5%) and ~$30 million incremental improvement; debottlenecking and targeted product ramps to improve utilization. Management is cautious on macro uncertainty but emphasizes controllable levers to restore earnings and cash flow.
Q4-2025 Updates
Positive Updates
Substantial Cost Reduction Program Delivered and Expanded
Delivered $100 million of cost reductions in 2025 (reported as $25 million above target) and targeting an additional $125–$150 million in 2026, implying $225–$250 million of savings over two years to boost margins and cash flow.
Circular/Methanolysis (rPET) Momentum and Revenue Growth
Kingsport methanolysis / rPET ramp driving revenue growth (company cites a 4%–5% revenue increase contribution and an incremental ~$30 million improvement versus 2025), with multiple large-brand contracts (including Pepsi) and customers pulling rPET demand forward due to mechanical-recycling quality degradation.
ETP Project to Reduce CI Volatility with Strong Economics
ETP project (convert bulk ethylene to propylene) is expected to structurally improve Chemical Intermediates earnings by ~$50–$100 million with a payback of under two years, removing bulk ethylene exposure and improving propylene margins.
Debottlenecking and Capacity Efficiency
Kingsport debottlenecking can increase throughput by ~130%, allowing more use of first-plant capacity before committing to second-plant CapEx and improving ROIC.
Targeted Volume/Portfolio Growth Initiatives
Multiple growth levers: ramping Naia staple fibers for textile markets, expanding Aventa cellulosics (food trays, cutlery, straws), architectural interlayers regained, and targeting lower-margin but high-utilization polyester markets (heavy gauge sheet, shrink packaging) to lift utilization and overall margins.
High-Purity Solvents and Specialty Products with Above-Average Growth
High-purity solvents serving semiconductors and other specialty products are growing at high rates (cited 20%–30% growth) and have margins above the segment average, contributing incremental earnings.
Improving Utilization Tailwind Expected for 2026
Company expects a utilization benefit of $25–$50 million in 2026 from fewer shutdowns, lower planned maintenance, and volume recovery, with a focus on converting utilization and cost savings into earnings.
Negative Updates
Fibers Earnings and Volume Pressures
Fibers business experienced significant weakness (analyst cited ~19% volume decline in tow), with tow and textile mix pressures; company noted tariffs drove a ~$30 million decline in textile EBIT, destocking and lower utilization drove ~$20 million headwind, and energy costs added ~$15 million of pressure.
Chemical Intermediates Market Weakness
Bulk ethylene market and export demand are challenged (Chinese pricing/exports depressing margins), creating earnings volatility in CI; company is not banking on broad market recovery in 2026 and sees CI recovery as uncertain absent structural actions (e.g., ETP).
Modest Price Pressure Across Businesses
Management expects modest price declines in some areas (fibers and parts of Advanced Materials) as raw-material benefits are shared with customers; some contracts only have partial CPT pass-through so price/cost mismatches remain a headwind.
Variable Compensation and P&L Headwind
Variable compensation is expected to be a headwind in 2026 as prior-year target shortfalls reduce payouts; management estimates a $50–$75 million negative impact year-over-year depending on performance scenarios.
Second Methanolysis Project On Hold / DOE Grant Loss
Work on a second methanolysis plant was paused after losing the DOE grant; engineering spend has been halted and the company is re-evaluating a more capital-efficient second-plant approach, delaying some growth potential.
Near-Term Demand Uncertainty and Q1 Headwinds
Q1 guidance expected to be soft (quarterly flexibility in fiber contracts, expected modest Q1 volume shortfall), and management flagged macro uncertainty, consumer weakness and potential winter-storm impacts on energy costs; Q1 results exclude potential storm impacts.
Regulatory and Product Discontinuations
Discontinued certain European crop-protection products due to regulatory bans, which were profitable and will negatively impact results in the near term.
Company Guidance
Management guided to a stabilization-and-recovery path anchored in cost reductions, utilization gains and circular growth: they delivered $100M of cost saves in 2025 (≈$25M above plan) and target another $125–150M in 2026 (bringing total to ~$225–250M over two years); they noted last year’s EBIT hit included ~40% non‑tow impacts (about $30M tariff-driven, ~$20M utilization shortfall and ~$15M higher energy), expect a Q1 that starts soft (guidance excludes potential winter‑storm effects), and forecast a 2026 utilization tailwind of $25–50M (after a ~$100M 2025 utilization headwind) plus ≈$20M lower maintenance offset by a $50–75M variable‑comp headwind. Key growth drivers include circular/methanolysis (management cited ~+$30M incremental vs. 2025 and ~4–5% revenue growth from rPET/Kingsport ramps), the ETP ethylene→propylene project (potential ~$50–100M earnings uplift with <2‑year payback), and niche add‑ons (high‑purity solvents growing ~20–30% on a small base); management said an upper‑end EPS improvement near ~$5.50–$6/share is “in range” but emphasized wide macro uncertainty.

Eastman Chemical Financial Statement Overview

Summary
Fundamentals are sound but weakened in the latest year: profitability stepped down in 2025 (lower revenue and margins), cash conversion has been inconsistent despite positive FCF, and returns cooled. Balance sheet metrics look generally reasonable, though a 2025 total-debt data anomaly reduces confidence in the leverage read-through.
Income Statement
63
Positive
Profitability has been solid historically (net margins around 7–10% in 2021–2024), but 2025 saw a clear step-down: revenue fell ~3% and net margin dropped to ~5% with lower EBIT/EBITDA margins versus prior years. The business shows some cyclicality (notably the 2023 revenue decline), and the latest year signals weaker pricing/mix and/or cost pressure relative to the stronger 2023–2024 period.
Balance Sheet
72
Positive
Leverage was moderate in 2020–2024 with debt-to-equity roughly ~0.87–1.00, and equity has remained sizeable and relatively stable. Returns on equity were strong in 2021–2024 (~15–16%) but cooled meaningfully in 2025 (~8%), consistent with the earnings decline. A major data flag is 2025 showing total debt as 0, which is a sharp break from prior years and may reflect reporting/classification rather than an actual elimination of debt; excluding that, the balance sheet reads as reasonably levered for a specialty chemicals company.
Cash Flow
58
Neutral
Cash generation is positive, but conversion has been inconsistent. Free cash flow improved in 2023–2025 (including growth in 2025), yet operating cash flow coverage is modest across the period (~0.30–0.71) and free cash flow has often been only ~37–73% of net income, dropping to ~44% in 2025. This points to working-capital swings and/or higher capital intensity that can pressure cash availability during weaker earnings years.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.75B9.38B9.20B10.54B10.48B
Gross Profit1.84B2.29B2.06B2.06B2.52B
EBITDA1.29B1.80B1.81B1.64B1.81B
Net Income474.00M905.00M894.00M793.00M857.00M
Balance Sheet
Total Assets14.86B15.21B14.63B14.67B15.52B
Cash, Cash Equivalents and Short-Term Investments566.00M837.00M548.00M493.00M459.00M
Total Debt5.08B5.26B5.14B5.15B5.52B
Total Liabilities8.82B9.36B9.10B9.43B9.73B
Stockholders Equity5.96B5.78B5.46B5.15B5.70B
Cash Flow
Free Cash Flow424.00M688.00M546.00M364.00M1.04B
Operating Cash Flow970.00M1.29B1.37B975.00M1.62B
Investing Cash Flow-462.00M-534.00M-432.00M392.00M-29.00M
Financing Cash Flow-797.00M-454.00M-888.00M-1.32B-1.69B

Eastman Chemical Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price75.47
Price Trends
50DMA
70.32
Positive
100DMA
65.31
Positive
200DMA
68.17
Positive
Market Momentum
MACD
2.23
Positive
RSI
51.48
Neutral
STOCH
10.61
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EMN, the sentiment is Neutral. The current price of 75.47 is below the 20-day moving average (MA) of 76.63, above the 50-day MA of 70.32, and above the 200-day MA of 68.17, indicating a neutral trend. The MACD of 2.23 indicates Positive momentum. The RSI at 51.48 is Neutral, neither overbought nor oversold. The STOCH value of 10.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for EMN.

Eastman Chemical Risk Analysis

Eastman Chemical disclosed 15 risk factors in its most recent earnings report. Eastman Chemical reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Eastman Chemical Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$8.94B46.647.55%1.25%3.87%-10.30%
68
Neutral
$8.80B18.818.07%5.33%-3.33%-19.59%
66
Neutral
$5.82B13.9525.75%1.59%-1.11%5.15%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
$22.02B-34.03-5.24%1.10%-23.92%90.47%
55
Neutral
$13.36B-8.80-15.56%2.88%-5.32%-1108.29%
50
Neutral
$6.21B-11.65-9.20%-3.59%-126.16%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EMN
Eastman Chemical
75.22
-18.31
-19.57%
ALB
Albemarle
184.93
109.47
145.07%
NEU
Newmarket
628.84
68.22
12.17%
WLK
Westlake Corporation
100.34
-9.01
-8.24%
ESI
Element Solutions
35.71
9.94
38.56%
AVTR
Avantor
9.01
-7.69
-46.05%

Eastman Chemical Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Eastman Chemical Issues $600 Million Senior Notes Offering
Positive
Feb 20, 2026

On February 20, 2026, Eastman Chemical Company issued $600 million of 4.500% unsecured notes due 2031 in a public offering, with interest payable semi-annually and optional redemption features that allow early repayment under specified make-whole and par call terms. The notes, which rank equally with Eastman’s other unsecured, unsubordinated debt and include covenants limiting secured borrowing and certain transactions, also feature change-of-control protections that could trigger a repurchase at 101% of principal plus accrued interest.

The sale, underwritten by a syndicate led by major global banks, is expected to generate approximately $593.7 million in net proceeds after underwriting discounts and expenses. Eastman plans to use the funds for general corporate purposes, including working capital, capital expenditures, potential debt repayment and support of its strategic initiatives, reinforcing financial flexibility and funding capacity for ongoing operational and growth plans.

The most recent analyst rating on (EMN) stock is a Hold with a $75.00 price target. To see the full list of analyst forecasts on Eastman Chemical stock, see the EMN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 22, 2026